Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0011155,
umls-concept:C0017725,
umls-concept:C0020663,
umls-concept:C0030705,
umls-concept:C0032105,
umls-concept:C0037668,
umls-concept:C0040300,
umls-concept:C0205307,
umls-concept:C0332120,
umls-concept:C0332240,
umls-concept:C0391871,
umls-concept:C0441889,
umls-concept:C0442027,
umls-concept:C0597879,
umls-concept:C0681850,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
1
|
pubmed:dateCreated |
1987-1-16
|
pubmed:abstractText |
Using a specific and sensitive RIA for GH-releasing hormone (GHRH), we examined the effect of oral administration of 75 g glucose on peripheral plasma GHRH-like immunoreactivity (GHRH-LI) in normal subjects (n = 12) and patients with idiopathic GH deficiency (IGHD) (n = 6). The normal subjects had two peaks of plasma GHRH-LI after oral glucose administration. The initial peak GHRH-LI levels occurred 30-150 min after glucose ingestion and corresponded to an increase in blood glucose. The increment in plasma GHRH-LI levels 30 min after glucose ingestion [7.4 +/- 2.4 (+/- SEM) pg/ml] was significantly higher (P less than 0.05) than that during a control study. Second peaks in plasma GHRH-LI occurred 3.5-6 h after glucose ingestion, and the mean increment 5 h after glucose ingestion was 9.4 +/- 2.4 pg/ml. This second rise of plasma GHRH-LI coincided with a significant increase in plasma GH after reactive hypoglycemia. This second GHRH-LI peak and the rise of plasma GH after hypoglycemia were absent in patients with IGHD, whereas the first peak of plasma GHRH-LI appeared shortly after glucose ingestion in these patients as well as in normal subjects. In addition, hypoglycemia produced by iv injection of regular insulin (0.1 U/kg) was not accompanied by increases in plasma GHRH-LI and GH levels in patients with IGHD, whereas insulin-induced hypoglycemia resulted in significant elevations of both plasma GHRH-LI and GH levels in normal subjects. These findings suggest that peripheral plasma GHRH-LI is derived from the hypothalamus as well as from an extrahypothalamic source(s); extrahypothalamic GHRH is released shortly after glucose ingestion; and secretion of GHRH from the hypothalamus is stimulated by hypoglycemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
92-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3097059-Adolescent,
pubmed-meshheading:3097059-Adult,
pubmed-meshheading:3097059-Blood Glucose,
pubmed-meshheading:3097059-Child,
pubmed-meshheading:3097059-Female,
pubmed-meshheading:3097059-Glucose,
pubmed-meshheading:3097059-Glucose Tolerance Test,
pubmed-meshheading:3097059-Growth Hormone,
pubmed-meshheading:3097059-Growth Hormone-Releasing Hormone,
pubmed-meshheading:3097059-Humans,
pubmed-meshheading:3097059-Hypoglycemia,
pubmed-meshheading:3097059-Hypothalamus,
pubmed-meshheading:3097059-Insulin,
pubmed-meshheading:3097059-Male,
pubmed-meshheading:3097059-Tissue Distribution
|
pubmed:year |
1987
|
pubmed:articleTitle |
Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|